Bvf Partners L P/Il - Insider Trading & Ownership

Location
44 Montgomery St., 40 Th Floor, San Francisco, CA
Summary
The estimated value of insider holdings of Bvf Partners L P/Il is at least $166M dollars as of October 14, 2025. Bvf Partners L P/Il is the 10%+ Owner of XOMA Royalty Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $63.5M. Bvf Partners L P/Il is the Director, 10%+ Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $52M. Bvf Partners L P/Il is the Director, Other* of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $17.8M. Bvf Partners L P/Il is the 10%+ Owner of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $10.9M. Bvf Partners L P/Il is the 10%+ Owner of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $6.47M. Bvf Partners L P/Il is the Director, Other* of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $3.72M. Bvf Partners L P/Il is the 10%+ Owner of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $3.63M. Bvf Partners L P/Il is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $2.96M. Bvf Partners L P/Il is the Other* of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $2.53M. Bvf Partners L P/Il is the Other* of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $1.44M. Bvf Partners L P/Il is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $799K. Bvf Partners L P/Il is the Other* of PIERIS PHARMACEUTICALS, INC. and owns shares of PALVELLA THERAPEUTICS, INC. (PVLA) stock worth about $619K. Bvf Partners L P/Il is the 10%+ Owner of CRESCENT BIOPHARMA, INC. and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $15.6K.
Signature
BVF Partners L.P., By: BVF Inc., its general partner, By: /s/ Mark N. Lampert, President
All Insider Reports
All Insider Reports

Ownership of Bvf Partners L P/Il

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XOMA, XOMAO XOMA Royalty Corp 10%+ Owner $63.5M -$27.6M -30.3% May 16, 2025
MLTX MoonLake Immunotherapeutics Director, 10%+ Owner $52M Jun 5, 2025
KYMR Kymera Therapeutics, Inc. Director, Other* $17.8M +$14M +367% Jun 25, 2025
VSTM Verastem, Inc. 10%+ Owner $10.9M Jan 25, 2022
MRUS Merus N.V. 10%+ Owner $6.47M Oct 7, 2021
OLMA Olema Pharmaceuticals, Inc. Director, Other* $3.72M Jun 11, 2025
ELDN Eledon Pharmaceuticals, Inc. 10%+ Owner $3.63M Oct 29, 2024
RPTX Repare Therapeutics Inc. 10%+ Owner $2.96M Nov 15, 2023
THRD Third Harmonic Bio, Inc. Other* $2.53M Oct 29, 2024
FDMT 4D Molecular Therapeutics, Inc. Other* $1.44M Nov 8, 2024
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $799K Jan 19, 2023
PVLA PALVELLA THERAPEUTICS, INC. Other* $619K Dec 13, 2024
GLYC GLYCOMIMETICS INC 10%+ Owner $15.6K Jun 13, 2025
ALLK Allakos Inc. 10%+ Owner $0 May 15, 2025
EPIX ESSA Pharma Inc. 10%+ Owner $0 -$293 -100% Oct 9, 2025
RAIN Rain Oncology Inc. Director, Other* $0 Jan 25, 2024
CTIC CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Jun 26, 2023
ENGN, ENGNW enGene Holdings Inc. 10%+ Owner Oct 31, 2023
PNT POINT Biopharma Global Inc. Former 10% Owner Dec 18, 2023
GPCR Structure Therapeutics Inc. 10%+ Owner May 10, 2023

Insider Transactions Reported by Bvf Partners L P/Il:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.